CCO Medical Specialties Podcast
25 episodes - English - Latest episode: 25 days ago -Weekly updates on new data, current advances, and best practices in patient care for a variety of medical specialties including NASH, diabetes, muscular dystrophy, and more from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.
Homepage Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
How to Implement Earlier Hepatitis B Treatment
March 26, 2024 18:30 - 21 minutes - 19.7 MBIn this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness considerations Integration of patient perspectives in wider treatment Presenters: Mark S. Sulkowski, MD, FIDSA, FAASLD Professor of Medicine Di...
The Art of Multidisciplinary Care for Patients With Metabolic Dysfunction–Associated Steatohepatitis
March 13, 2024 16:50 - 29 minutes - 27.2 MBIn this episode, Arun B. Jesudian, MD, and Mazen Noureddin, MD, MHSc, discuss the expert-informed clinical pathway for the multidisciplinary care of patients with MASLD or MASH, current and emerging therapeutics, and management optimization strategies. Presenters: Arun B. Jesudian, MD Associate Professor of Clinical Medicine Division of Gastroenterology and Hepatology Weill Cornell Medicine New York, New York Mazen Noureddin, MD, MHSc Professor of Medicine Houston Methodist Hospital Dire...
Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients
February 12, 2024 15:09 - 32 minutes - 29.7 MBIn this episode, Jennifer Green, MD, and Carol Hatch Wysham, MD, break down the latest headlines on incretin-based therapies and how to address these topics with patients. Their discussion includes: Beneficial effects beyond glycemic control Adverse events and how to manage them Non- or partial responders and the importance of setting expectations with patients Weight rebound when discontinuing therapy Medication access issues related to cost and drug availability Presenters: Jenni...
How to Implement Earlier Hepatitis B and Hepatitis Delta Screening
December 22, 2023 05:00 - 27 minutes - 25.7 MBIn this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screening for HBV Addressing patient-, provider-, and system-level barriers to universal HBV screening Best practices for implementation of HDV scree...
Being Your Full Self: Pursuing Work–Life Balance
September 25, 2023 20:30 - 28 minutes - 26.2 MBIn this podcast episode, Aline Charabaty, MD, AGAF, FACG, and Christina Tennyson, MD, DipABLM, discuss how women in gastroenterology (GI) can fight burnout and establish a work–life balance that meets their needs. Tune in to learn how to say no, about the importance of saying yes to meaningful things that will advance your career and bring you joy, and get essential tips for well-rounded and ongoing self-care. Presenters: Dr Aline Charabaty is an Assistant Professor of Medicine at John...
Embracing Your Value: Tools and Strategies for Optimizing Professional Growth and Development
September 25, 2023 20:30 - 29 minutes - 27.5 MBIn this podcast episode, Anita Afzali, MD, MPH, MHCM, FACG, AGAF, and Aja McCutchen, MD, discuss how women in gastroenterology (GI) can embrace and enhance their value. These inspiring GI medicine experts propose a practical formula that involves ongoing, careful self-reflection and asking yourself how your strengths, core values, and interests can be aligned with professional endeavors. In addition, self-advocacy and self-allyship can serve as harmonious tools to drive action and positive c...
Finding Your Friendtors: Mentors, Sponsors, and Allies
September 25, 2023 20:30 - 28 minutes - 26.6 MBIn this podcast episode, Aline Charabaty, MD, AGAF, FACG, and Marla Dubinsky, MD, discuss how women in gastroenterology (GI) can find their “friendtors” and build a strong network of mentors, sponsors, and allies. Although there may be many barriers for women in the GI medicine specialty, these experienced leaders have useful tips to help emerging healthcare professionals avoid internalizing these challenges and strategically focus on accomplishing their goals. Presenters: Dr Aline Cha...
Addressing Health Disparities in Anemia of Chronic Kidney Disease
December 07, 2022 21:30 - 22 minutes - 21.1 MBThis podcast episode is part of a multimedia program discussing the impact of health disparities in anemia of chronic kidney disease (CKD) on patient outcomes. Tune in to hear Santosh Saraf, MD, and Milda Saunders, MD, MPH, highlight mitigation strategies to improve screening and management. The overview will include: The definition of CKD and the relative prevalence in specific minority groups How health disparities affect CKD-related clinical and patient outcomes Appropriate screening ...
Key Points in the Management of Lupus and Lupus Nephritis
June 06, 2022 21:05 - 24 minutes - 22.8 MBIn this episode, listen as Karen H. Costenbader, MD, MPH, and Brad H. Rovin, MD, answer key questions about identifying patients at high risk for lupus nephritis, whether an elevated serum creatinine always signals lupus nephritis, the safety of newer therapies for lupus in women who are pregnant or breastfeeding, and the possibility of using SGLT2 inhibitors in patients with lupus nephritis. Presenters: Karen H. Costenbader, MD, MPH Professor of Medicine Department of Medicine Harvard Me...
Interview with the Experts: Strategies to Overcome SDOH in NVAF Part 2
June 03, 2022 16:45 - 15 minutes - 13.9 MBIn this episode, David S. Kountz, MD, discusses with Keith C. Ferdinand MD, FACC, FAHA, a patient case in which health disparities affected NVAF care and provides patient, provider, and health-system level strategies to address these disparities to improve NVAF-related cardiovascular outcomes. Presenters Keith C. Ferdinand, MD, FACC, FAHA Professor of Medicine Tulane Heart and Vascular Institute Tulane University School of Medicine New Orleans, Louisiana David S. Kountz, MD Professor of ...
Interview With the Experts: Strategies to Overcome SDOH in NVAF Part 1
June 03, 2022 16:40 - 13 minutes - 12.2 MBIn this episode, Keith C. Ferdinand MD, FACC, FAHA, discusses with David S. Kountz, MD, a patient case in which health disparities affected NVAF care and provides strategies to address low health literacy and patient access to direct-acting oral anticoagulant to improve NVAF-related cardiovascular outcomes. Presenters Keith C. Ferdinand, MD, FACC, FAHA Professor of Medicine Tulane Heart and Vascular Institute Tulane University School of Medicine New Orleans, Louisiana David S. Kountz, M...
Reducing Disparities in Lupus and Lupus Nephritis Care
June 02, 2022 19:00 - 20 minutes - 18.5 MBIn this episode, Karen H. Costenbader, MD, MPH, and Brad H. Rovin, MD, discuss health disparities in systemic lupus erythematosus and lupus nephritis. Topics include: Disproportionate prevalence among marginalized groups in the United States Lupus-related social determinants of health Challenges with medication adherence Strategies to reduce these disparities Presenters: Karen H. Costenbader, MD, MPH Professor of Medicine Department of Medicine Harvard Medical School Director, Lupus P...
Overview of SDOH in NVAF and CV-Related Outcomes
May 26, 2022 16:10 - 11 minutes - 10.4 MBThis podcast is the first in a series of 3 featuring an multidisciplinary panel of expert faculty addressing the impact of social determinants of health on NVAF and CV-related outcomes and strategies to overcome these disparities. In this episode, David S. Kountz, MD, provides a detailed explanation of the atrial fibrillation paradox and data on the impacts of SDOH on NVAF CV-related outcomes. Review the downloadable slideset and the full program at: https://bit.ly/3yYXP8e
Strategies to Overcome SDOH in NVAF
May 26, 2022 16:10 - 18 minutes - 16.6 MBThis podcast is the second in a series of 3 featuring an expert multidisciplinary panel of faculty addressing the impact of social determinants of health on NVAF and CV-related outcomes and strategies to overcome these disparities. In this episode, Laura Ross PA-C, CLS, dives deeper into the impacts of SODH on NVAF care and provides strategies to address to improve patient care and clinical outcomes in NVAF. Review the downloadable slideset and the full program at: https://bit.ly/3yYXP8e
NVAF Management and Future Directions
May 26, 2022 16:10 - 20 minutes - 18.9 MBThis podcast is the third in a series of 3 featuring an expert multidisciplinary panel of faculty addressing the impact of social determinants of health on NVAF and CV-related outcomes and strategies to overcome these disparities. In this episode, Keith C. Ferdinand, MD, FACC, FAHA, details the effects of SDOH on anticoagulation prescribing in NVAF and provides an overview of areas for future study. Review the downloadable slideset and the full program at: https://bit.ly/3yYXP8e
A Closer Look at RA Treatment: JAK Inhibitor Efficacy and Safety
December 11, 2020 22:30 - 43 minutes - 29.7 MBIn this episode, Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman interpret the latest safety and efficacy data for JAK inhibitors in RA, including the ORAL, BEACON, BEAM, SELECT, and FINCH series in bDMARD-IR MTX-IR MTX naive Also included is an in-depth discussion of JAK safety, including MACE and VTE, and use in the clinic including JAK cycling Presenters: Stanley B. Cohen, MD Clinical Professor Department of Internal Medicine University of Texas Southwestern Medical Scho...
A Closer Look at RA Treatment: Targeted DMARDs
December 11, 2020 22:30 - 10 minutes - 7.14 MBIn this episode, Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman discuss the recent changes in rheumatoid arthritis treatment options, reviewing the landscape of targeted DMARDs and JAK inhibitors, including: Kinase signaling JAK inhibitor activity and signaling JAK selectivity Presenters: Stanley B. Cohen, MD Clinical Professor Department of Internal Medicine University of Texas Southwestern Medical School Co-Director Division of Rheumatology Presbyterian Hospital Co-Medic...
A Closer Look at RA Treatment: Treat-to-Target Using Shared Decision-Making
December 11, 2020 22:25 - 25 minutes - 17.7 MBIn this episode, Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman discuss how to translate information on JAK inhibitors and other treatments for your patient population in the clinic, covering practical tips on using: Treat-to-target approaches Disease activity measures Shared decision-making Decision aids Translating clinical trial evidence Also included are the experts’ answers to questions from clinicians like you. Stanley B. Cohen, MD Clinical Professor Department of I...
Managing Weight in NAFLD/NASH
July 08, 2020 20:13 - 50 minutes - 45.8 MBWhat should our patients with NAFLD eat? Listen as expert hepatologist Rotonya Carr, MD, explores the evidence behind different diets in NAFLD/NASH. Download the slides from this podcast at: https://bit.ly/3gpzuMj See more NASH topics at: https://bit.ly/3ezkBq6
NASH Screening in Diabetes
July 07, 2020 21:16 - 43 minutes - 29.4 MBHear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk, including: Should We Screen for NASH? Role of obesity and type 2 diabetes mellitus Cardiovascular Risk in NAFLD/NASH How to Evaluate for NAFLD/NASH Biomarkers Imaging When/whom to biopsy? Management in Multidisciplinary Settings Download the slides from this podcast at: https://bit.ly/2ZBvVvy See more NASH topics at: https://bit.ly/3ezkBq6
Noninvasive Tests for NASH
July 07, 2020 18:29 - 43 minutes - 31.1 MBHear Stephen A. Harrison, MD, COL (Ret.), FAASLD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests in NASH, including their use in: • Diagnosis of NASH patients with NAS ≥ 4 and fibrosis ≥ F2 • Assessment of therapeutic response • Assessment of long-term patient outcomes Download the slides from this podcast at: https://bit.ly/3il5rqG See more NASH topics at: https://bit.ly/3ezkBq6
Current NASH Treatments
July 02, 2020 17:31 - 37 minutes - 33.9 MBHear Philip N. Newsome, PhD, FRCPE, discussavailable approaches to managing NASH, including lifestyle, vitamin E, and compounds that target insulin resistance, including: Recommended Pharmacologic Therapies for NASH Pioglitazone Vitamin E Optimal Diabetes Therapies in NAFLD/NASH Weight Loss Liver Health Surgical Approaches to Weight Loss and Effect on Liver Download the slides from this podcast at: https://bit.ly/3ig0r6x See more NASH topics at: https://bit.ly/3ezkBq6
New Developments in Gene Therapy for Muscular Dystrophy
July 02, 2020 17:30 - 50 minutes - 46.1 MBHear Dr. Katherine Wagner *and *Dr. Richard Finkle discussnovel gene-based approaches to treating patients with Duchenne muscular dystrophy and limb girdle muscular dystrophies. The latest clinical trial data and gene therapy considerations for product selection including AAV mini-dystrophin and other investigational therapies will be explored. Download the slides from this podcast at: https://bit.ly/2zZgB2X See more neurology topics at: https://bit.ly/3eAMVby
Emerging NASH Treatments
July 01, 2020 18:49 - 40 minutes - 36.4 MBHear Philip N. Newsome, PhD, FRCPE, discuss the agents in late-phase clinical trials and their potential use in the treatment of NASH and fibrosis, including those in phase III such as: Obeticholic acid Cenicriviroc Resmetirom Aramchol Download the slides from this podcast at: https://bit.ly/3eJYKvW See more NASH topics at: https://bit.ly/3ezkBq6
Role of the Diabetes Care and Education Specialist in CGM
March 31, 2020 17:35 - 14 minutes - 13.6 MBLink to CME: Claim Credit - https://bit.ly/3dQPQwT . Continuous glucose monitoring (CGM) is a great tool that improves clinical outcomes for people with diabetes; these individuals are often happy to get this new technology. However, there can be some initial barriers that both people with diabetes and clinicians need to overcome. BARRIER 1: Wearing something on the body so other people know the person has diabetes. SOLUTION 1: Let the person see the size of different devices through dem...